# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-18-004081
Filing Date
2018-04-05
Accepted
2018-04-05 08:30:30
Documents
34
Period of Report
2018-04-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | f8k040418_relmadatherap.htm | 8-K | 27368
2 | RELMADA THERAPEUTICS, INC. CORPORATE PRESENTATION, DATED APRIL 2018 | f8k040418ex99-1_relmada.htm | EX-99.1 | 42310
3 | GRAPHIC | image_001.jpg | GRAPHIC | 94765
4 | GRAPHIC | image_002.jpg | GRAPHIC | 249674
5 | GRAPHIC | image_003.jpg | GRAPHIC | 209583
6 | GRAPHIC | image_004.jpg | GRAPHIC | 142308
7 | GRAPHIC | image_005.jpg | GRAPHIC | 94288
8 | GRAPHIC | image_006.jpg | GRAPHIC | 212506
9 | GRAPHIC | image_007.jpg | GRAPHIC | 260492
10 | GRAPHIC | image_008.jpg | GRAPHIC | 291513
11 | GRAPHIC | image_009.jpg | GRAPHIC | 256682
12 | GRAPHIC | image_010.jpg | GRAPHIC | 137360
13 | GRAPHIC | image_011.jpg | GRAPHIC | 162116
14 | GRAPHIC | image_012.jpg | GRAPHIC | 248805
15 | GRAPHIC | image_013.jpg | GRAPHIC | 202134
16 | GRAPHIC | image_014.jpg | GRAPHIC | 105408
17 | GRAPHIC | image_015.jpg | GRAPHIC | 216929
18 | GRAPHIC | image_016.jpg | GRAPHIC | 185104
19 | GRAPHIC | image_017.jpg | GRAPHIC | 253248
20 | GRAPHIC | image_018.jpg | GRAPHIC | 190440
21 | GRAPHIC | image_019.jpg | GRAPHIC | 87825
22 | GRAPHIC | image_020.jpg | GRAPHIC | 180997
23 | GRAPHIC | image_021.jpg | GRAPHIC | 210809
24 | GRAPHIC | image_022.jpg | GRAPHIC | 146058
25 | GRAPHIC | image_023.jpg | GRAPHIC | 92312
26 | GRAPHIC | image_024.jpg | GRAPHIC | 198532
27 | GRAPHIC | image_025.jpg | GRAPHIC | 66247
28 | GRAPHIC | image_026.jpg | GRAPHIC | 209158
29 | GRAPHIC | image_027.jpg | GRAPHIC | 170463
30 | GRAPHIC | image_028.jpg | GRAPHIC | 153674
31 | GRAPHIC | image_029.jpg | GRAPHIC | 76559
32 | GRAPHIC | image_030.jpg | GRAPHIC | 114193
33 | GRAPHIC | image_031.jpg | GRAPHIC | 166968
34 | GRAPHIC | image_032.jpg | GRAPHIC | 120357
| Complete submission text file | 0001213900-18-004081.txt |  | 7659828

Mailing Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016
Business Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016 646-677-3853
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55347 | Film No.: 18739359
SIC: 2834 Pharmaceutical Preparations